Why it matters: The move could open the task force up to more political influence. It comes as the administration prepares to vet new applicants to the committee, a process in which the chairs would typically be involved.
GHO Capital of London has agreed to merge with Singapore-based rival CBC Group, forming a dedicated health care investment firm with over $21 billion in assets under management.
Why it matters: This is about scaling for survival, as generalist PE giants have begun to crowd out smaller players in health care.
An Ebola outbreak in parts of Central and East Africa is fueling concern about another global health crisis.
Why it matters: WHO this week declared Ebola a public health emergency of international concern, but experts say the chances of a global pandemic remain slim.
Finding a new commissioner is only the beginning of what the Trump administration needs to do to rebuild the Food and Drug Administration — and none of it is easy.
Why it matters: More than a year of upheaval has left the agency's leadership decimated and its reputation for predictable, evidence-based decisions damaged.
The ongoing Ebola surge has public health experts anxious about the world's capacity to contain its spread.
The big picture: Ebola epidemics aren't new, but the current outbreak has been identified as the rare Bundibugyo strain, which has no vaccine, and is located in a populated, mobile and conflict-stricken part of the world.
Do you dread making small talk or getting drawn into a dull conversation about the weather?
Buck up! Conversations about topics people think are boring typically wind up being enjoyable, according to an intriguing study recently published in the Journal of Personality and Social Psychology.
Why it matters: Social interaction is good for you — plenty of research finds it enhances well-being and makes people feel happy.
The Food and Drug Administration is easing restrictions on unauthorized vapes and scrapping a proposed ban on minors using tanning beds, reflecting a tumultuous shift in priorities during the MAHA era.
The big picture: The moves risk weakening federal efforts to protect teens from unhealthy habits and emboldening industries that market addictive or high-risk products, public health experts warn.
The drug industry struck out at the Supreme Court on Monday in its ongoing efforts to scuttle Medicare drug price negotiations.
Why it matters: It's the latest rebuff to industry arguments that the talks with the government violate free speech protections and due process rights, among other complaints.
The negotiated prices that took effect this year are expected to generate $1.5 billion in savings to patients and $6 billion to Medicare.
Hospitals are bracing for a sweeping rewrite of federal health privacy rules that could result in more penalties for cybersecurity breachesand add billions of dollars in costs.
Why it matters: Spurred by the massive Change Healthcare hack in 2024, the changes reflect a growing belief that at least some health care breaches are preventable and that hospitals should be required to meet baseline security standards.
